Iododeoxyuridine labelling of S-phase fraction in fine needle aspirates from breast carcinomas R A Maas, P F Bruning, A J Breedijk, J L Peterse Abstract The suitability of measuring the S-phase fraction in human breast cancer by labelling tumour cells from fine needle aspirates (FNAs) in vitro with iododeoxyuridine (IdU) was studied in 11 patients. The S-phase fraction was measured both in preoperative FNAs labelled in vitro with IdU, and in FNAs taken from the same tumour when surgically removed after intravenous administration ofIdU. Frozen sections were also immunostained for incorporated IdU. The mean S-phase fraction measured in FNAs after in vitro or in vivo labelling and in sections after in vivo labelling was 4.0, 3.6, and 3.1, respectively. Results of in vitro and in vivo labelling of FNAs with IdU were similar. However, as the S-phase fraction in breast cancer is generally low, the variation between the different measurements is too large; therefore, the S-phase fraction is not a suitable indicator of response to treatment. Cytospin preparations were prepared, dried and washed in PBS. After being washed in PBS, frozen tumour sections were treated in the same way as the cytospin preparations. All samples were incubated in 95% formamide in PBS at 70°C for 45 minutes, washed three times for five minutes in 0.1 M Tris/HCl (pH 7.6) supplemented with 5% Tween 20, followed by a 10 minute wash in Tris/HCl (pH 7.6). After preincubation for 15 minutes in PBS supplemented with 0.5% Tween 20, 0.1% bovine serum albumin (BSA) and 10% normal rabbit serum, the preparations were incubated at room temperature with anti-IdU murine After two washes in PBS/BSA the preparations were incubated in biotinylated rabbit antimouse (Dako, Glostrup, Denmark), diluted 1 in 1000 in PBS/BSA/Tween/normal rabbit serum. Preparations were then washed twice in PBS/BSA followed by a 30 minute incubation with avidin/biotin horse radish peroxidase complex (Dako). After being washed twice in PBS/BSA and once in 0.1 M Tris/HCl (pH 7.4), the preparations were incubated with diaminobenzidine/imidazole/hydrogen peroxide in the dark at room temperature for six minutes. Samples were then washed in PBS and staining was enhanced by incubation in copper sulphate (0.5% CuSO4.5H20, 0.9% NaCl) at room temperature for five minutes. Finally, the preparations were rinsed in aquadest and a general nuclear staining was performed by incubation in haematoxylin for one to three minutes, followed by a four (fig 1) . Evaluation of S-phase fraction by different observers resulted in excellent conformity, with <5% interobserver variation. The data obtained in the 11 patients are summarised in fig  2. In one patient a large difference was found between the two FNAs and the frozen section, the latter having a much higher S-phase fraction (3, 6, and 21, respectively). This was due to the large number of dead cells present. The mean (SD) S-phase fraction in FNAs in the other 10 patients was 4.0 (2.5)% after in vitro labelling and 3.6 (1.9) % after in vivo labelling; analysis of tissue sections yielded a mean S-phase fraction of 3.1 (1.7)%. The mean S-phase fraction values were not significantly different (paired t test). The mean difference between the measurements on FNAs obtained prior to surgery and those taken from the surgical specimen was 2.6%. group.bmj.com on April 1, 2017 -Published by http://jcp.bmj.com/ Downloaded from information.2 3 The incorporation of IdU by tumour cells during S-phase can be measured by immunostaining. This method is more accurate than simple quantification of DNA by FACS analysis and avoids the use of ['H]-labelled thymidine. We have studied the reliability of assessing the S-phase fraction in FNAs by in vitro labelling with IdU as a more practical alternative to in vivo labelling. Both methods have disadvantages. In vivo, IdU may not penetrate the tumour completely and intra-tumoral concentrations of IdU vary from patient to patient, adversely affecting the sensitivity of the measurement. In vitro, aspiration may result in cell death, thereby giving a lower S-phase fraction. To control for these potential problems, we also measured the S-phase fraction in tumour sections after the in vivo administration of IdU.
The S-phase fraction was measured using all three methods in 1 1 of the 17 patients included in the study. In one patient the S-phase fraction measured in one of the FNAs was far too low. This was because most cells in the sample were dead. In the other 10 patients, however, no systematic increase or decrease in the S-phase fraction was noted when FNAs and frozen sections were compared. The results obtained with in vitro labelling are generally equivalent to those obtained with in vivo labelling. This suggests that administration of IdU to patients can be avoided.
The S-phase fraction in human breast cancer is generally low, the median value varying between 3.5 and 7.5.6 Because of this low figure and the variation caused by the labelling methods, analysis of FNAs after in vitro or in vivo labelling with IdU is not suitable for monitoring response to treatment. Sclerosing lymphocytic lobulitis is an inflammatory disorder of the breast that is well recognised in women. It has only been reported previously in two men; two further men with the condition are described here. Both presented with a breast mass, and one was an insulin dependent diabetic. Biopsy specimens from both patients showed circumscribed perivascular and, to a lesser extent, periductal collections of B and T lymphocytes. Sclerosing lymphocytic lobulitis in the female breast shows predominantly perilobular inflammation. The predominantly perivascular distribution in men is consistent with the relative paucity of epithelium in the male breast. Interlobular fibrosis with epithelioid fibroblasts was also present. Sclerosing lymphocytic lobulitis is a recently recognised disorder of the breast characterised by perilobular and perivascular aggregates of B and T lymphocytes, with increased expression of class II major histocompatibility antigens by the lobular and ductal epithelium, fibrosis and lobular atrophy."2 It is thought to be of autoimmune aetiology and is associated with other autoimmune diseases, particularly diabetes mellitus. The condition is well recognised in women, but has been reported in only two men.34 We describe two additional male patients in whom the perivascular and periductal inflammation has been characterised immunohistochemically.
Case reports Patient 1 was a 47 year old Algerian man who presented with a 15 mm mass in the right breast. He had had insulin dependent diabetes mellitus for 31 years, but no history of other autoimmune diseases. Patient 2 was a 53 year old Greek man who presented with a poorly defined 5 cm breast mass. He did not have diabetes mellitus nor any other autoimmune disease, nor a family history of diabetes. PATHOLOGICAL 
FINDINGS
An excision biopsy specimen was taken of the breast mass of both men. Sections from both
